Oscar Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2025: -0.91%

Oscar Health, Inc. EBITDA Margin is -0.91% for the Trailing 12 Months (TTM) ending June 30, 2025, a -181.25% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Oscar Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 1.11%, a -113.13% change year over year.
  • Oscar Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -8.48%, a -54.72% change year over year.
  • Oscar Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -18.74%, a -42.52% change year over year.
  • Oscar Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -32.59%.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin